查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球牙周藥物市場
市場調查報告書
商品編碼
1272772

2023-2030 年全球牙周藥物市場

Global Periodontal Therapeutics Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球牙周藥物市場預計將在 2022 年達到 7.348 億美元，並在 2030 年達到 614.593 億美元，並實現利潤豐厚的增長。 預計牙周病市場在預測期內（2023-2030 年）的複合年增長率為 9.2%。 使用抗生素後的輔助治療將支持這一市場趨勢。

牙周病的非手術治療，包括使用抗菌產品和口腔深層清潔，已被證明足以在早期逆轉牙周病。 局部和口服抗生素用於控制牙周炎症和牙菌斑。 口服抗生素放置在由微生物感染引起的牙齦和牙齒之間的空隙（通常稱為牙周袋）。

牙齦疾病從輕微到嚴重不等，如果不及時治療可能會導致牙齒脫落。 全球牙周藥物市場的主要增長因素是人們對口腔衛生重要性的認識不斷提高、人口老齡化以及新產品和新技術的開發。

市場動態

在預測期內，對更好的口腔健康的需求不斷增長推動了牙周藥物的全球市場增長

口腔衛生已成為保持身體健康的最重要參數之一。 因此，口腔衛生意識的增強正在推動牙周藥物市場的發展，尤其是在發達國家。 世界衛生組織 (WHO) 表示，超過 5.3 億兒童的乳牙患有齲齒。

寶潔 (Procter & Gamble) 和高露潔棕欖 (Colgate-Palmolive) 等領先公司致力於在兒童和成人中傳播牙齒衛生意識，從而創造對牙周藥物的需求。 由於口腔衛生意識的提高，預計全球牙周藥物市場在預測期內將快速擴張。

抗生素的臨床無效阻礙了牙周藥物市場的增長

抗生素在治療牙周病方面的部分無效一直是限制牙周藥物市場增長的關鍵因素。 抗生素在治療牙周病方面的應用受到限制，因為它們在治療細菌感染和癒合牙周袋方面效果不佳，尤其是在嚴重牙周炎的晚期。

抗生素治療主要與口腔手術和牙齒清潔程序結合使用。 此外，在疾病治療中過度使用或濫用抗生素會導致抗菌素耐藥性。 預計這些因素將阻礙預測期內牙周藥物市場的增長。

COVID-19 影響分析

由於 COVID-19 的爆發，全球牙周藥物市場不景氣。 2020 年上半年，用於治療牙周病的抗生素的銷售增長略有下降。 這可能是由於牙科護理的醫院就診次數減少以及全球牙醫的處方減少。

俄烏衝突分析

全球牙周治療市場可能會受到俄羅斯和烏克蘭之間持續衝突的間接影響。 多國因衝突對俄羅斯實施的經濟制裁波及俄羅斯經濟。 因此，包括牙周治療市場在內的牙科保健行業可能會受到影響。

牙科設備是從俄羅斯進口和出口的，因此戰爭的影響可能會阻礙俄羅斯向其他國家供應牙科設備。 此外，輝瑞、拜耳和賽諾菲等主要製藥公司推遲了在俄羅斯的新投資和開發，擾亂了藥品供應鏈。 這些由衝突驅動的破壞正在對全球牙周藥物市場產生負面影響。

了解有關此報告的更多信息 - 索取樣本

內容

第一章調查方法及範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按處理分類的片段
  • 按疾病類型分類的摘要
  • 按銷售渠道
  • 區域摘要

第四章市場動態

  • 影響因素
    • 主持人
      • 在預測期內，對更好的口腔衛生需求的增長推動了全球牙周藥物市場的增長
    • 約束因素
      • 抗生素的臨床無效阻礙了牙周藥物市場的增長
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法律法規分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第7章治療

  • 全身性抗生素
  • 外用抗生素

第 8 章按疾病類型分類

  • 牙齦炎
  • 慢性牙周炎
  • 進行性牙周炎
  • 壞死性牙周病
  • 其他

第 9 章分銷渠道

  • 零售藥店和藥店
  • 醫院藥房
  • 牙科診所
  • 電子商務

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第12章公司簡介

  • Kaken Pharmaceutical Co. Ltd.
    • 公司概況
    • 產品組合和說明
    • 財務摘要
    • 主要發展狀況
  • Bausch Health
  • Colgate-Palmolive
  • Medicom
  • Pfizer Inc.
  • 3M
  • Den-Mat Holdings, LLC
  • Dentsply Sirona
  • Xttrium Laboratories, Inc.
  • Dexcel Pharma

第13章 附錄

簡介目錄
Product Code: PH1888

Market Overview

The global periodontal therapeutics market reached US$ 734.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 61,459.3 million by 2030. The periodontal therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market.

The non-surgical treatment procedures for gum disease include the use of antibacterial products and deep cleaning of the mouth which is proven to be sufficient for reversing the periodontal disease in its early stages. Antibiotics including both topical and oral are prescribed for the control of inflammation and plaque of the gum tissue. Oral antibiotics are placed in the gaps formed between gums and teeth by microbial infection, commonly called periodontal pockets.

Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies.

Market Dynamics

The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period

Oral hygiene has become one of the most important parameters for staying healthy. Therefore, the growing awareness about oral hygiene is driving the periodontal therapeutics market, specifically in developed countries. The World Health Organization (WHO) states that over 530 million children suffer from dental caries of primary teeth.

Key players such as Procter & Gamble and Colgate-Palmolive Company have undertaken initiatives to spread awareness regarding dental hygiene, both for children and adults, creating demand for periodontal therapeutic drugs. Owing to rising awareness for better oral hygiene, the global periodontal therapeutics market will upscale at a rapid pace over the forecast period.

The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth.

The partial inefficiency of antibiotics in the treatment of periodontal disease is a key factor limiting the growth of the periodontal therapeutics market. The use of antibiotics in the treatment of gum disease is limited, especially in the later stages of severe periodontitis owing to the low efficiency of treating bacterial infection and healing pockets.

Antibiotic treatment is mostly used in combination with oral surgery or dental cleaning procedures. Furthermore, the overuse and misuse of antibiotics in disease treatment may result in antimicrobial resistance. These factors are expected to hamper the periodontal therapeutics market growth over the forecast period.

COVID-19 Impact Analysis

The global periodontal therapeutics market has experienced a downturn due to the outbreak of COVID-19. In the first half of 2020, there was a slight decrease in the sales growth of antibiotics used for the treatment of periodontal disease. This can be attributed to a reduction in hospital visits for dental services and a decrease in prescriptions from dentists around the world.

Russia Ukraine Conflict Analysis

The global periodontal therapeutic market may be indirectly affected by the ongoing conflict between Russia and Ukraine. Economic sanctions imposed on Russia by several countries due to the conflict have led to repercussions in the Russian economy. As a result, the dental healthcare industry, including the periodontal therapeutic market, may be impacted.

The supply of dental equipment from Russia to other countries may be disrupted due to the war, as Russia both imports and exports dental equipment. Additionally, major pharmaceutical companies such as Pfizer, Bayer, and Sanofi have deferred new investments or developments in Russia, which has led to disruptions in the medicine supply chain. These disruptions caused by the conflict have had a negative impact on the global periodontal therapeutics market.

For more details on this report - Request For Sample

Segment Analysis

The global periodontal therapeutics market is segmented based on treatment, disease type, distribution channel, and region.

Gingivitis segment to hold the highest global periodontal therapeutics market share

The gingivitis segment is expected to dominate and account for 54.7% of the global periodontal therapeutics market share over the forecast period. Gingivitis is one of the most common types of periodontitis. This is usually caused by poor oral hygiene and red, swollen gums. They also tend to bleed easily.

The treatment of gingivitis focuses on reducing inflammation, removing plaque, and establishing good oral hygiene habits to prevent plaque build-up. Mouthwash, topical antibiotics, or antiseptics may be recommended. For more serious infections or periodontitis, the dentist may recommend oral antibiotics. For instance, over-the-counter medicated toothpaste, mouth rinses, and mouth sprays are very safe, provided they are used as directed. Therefore, this segment growth will boost the global periodontal therapeutics market growth over the forecast period.

Geographical Analysis

The presence of major players to dominate the North America region.

North America is expected to have a dominant global periodontal therapeutics market share of around 1/3rd of this market. The U.S. is the largest revenue contributor in North America, and the presence of a large dental workforce in this region indicates its dominance in the global market. For instance, according to the American Dental Association, as of 2022, there are 202,536 professionally active dentists in the U.S. There are 60.8 dentists per 100,000 U.S. population.

Competitive Landscape

The major global players in the market include Kaken Pharmaceutical Co. Ltd., Bausch Health, Colgate-Palmolive, Medicom, Pfizer Inc., 3M, Den-Mat Holdings, LLC, Dentsply Sirona, Xttrium Laboratories, Inc., and Dexcel Pharma.

Why Purchase the Report?

  • To visualize the global periodontal therapeutics- market segmentation based on treatment, disease type, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global periodontal therapeutics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global periodontal therapeutics market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Treatment
  • 3.2. Snippet by Disease Type
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing demand for better oral hygiene to drive global periodontal therapeutics market growth during the forecast period
    • 4.1.2. Restraints
      • 4.1.2.1. The clinical inefficiencies of antibiotics to hamper periodontal therapeutics market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Treatment

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.1.2. Market Attractiveness Index, By Treatment
  • 7.2. Systemic Antibiotics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Local Antibiotics

8. By Disease Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 8.1.2. Market Attractiveness Index, By Disease Type
  • 8.2. Gingivitis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Chronic Periodontitis
  • 8.4. Aggressive Periodontitis
  • 8.5. Necrotizing Periodontal Disease
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Retail Pharmacies and Drug Stores*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospital Pharmacies
  • 9.4. Dental Clinics
  • 9.5. E-Commerce

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Kaken Pharmaceutical Co. Ltd.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Bausch Health
  • 12.3. Colgate-Palmolive
  • 12.4. Medicom
  • 12.5. Pfizer Inc.
  • 12.6. 3M
  • 12.7. Den-Mat Holdings, LLC
  • 12.8. Dentsply Sirona
  • 12.9. Xttrium Laboratories, Inc.
  • 12.10. Dexcel Pharma

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us